ClearLife Allergy Nasal Spray — Class I drug recall D-0289-2026
Ongoing recall by Medinatura New Mexico, inc., reported 2026-01-14, distributed nationwide. Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microb
| Recall number | D-0289-2026 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Medinatura New Mexico, inc., Albuquerque, NM, United States |
| Recall initiated | 2025-12-12 |
| Classified | 2026-01-15 |
| Reported by FDA | 2026-01-14 |
| Distributed | Nationwide (US) |
| Reason classes | microbial contamination, sterility |
| Pathogens | mold, yeast |
| UPC / GTIN / UDI-DI | 00787647101887 |
| NDC | 62795-4006, 62795-4006-09 |
Product
ClearLife Allergy Nasal Spray, Extra Strength, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNatura, 10421 Research Rd., SE, Albuquerque, NM 87123, NDC 62795-4006-9, UPC 787647101887
Reason for recall
Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0289-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.